J. Frénel and M. Campone, Chimioth??rapie des cancers du sein non m??tastatiques??: ??tat des lieux en 2010, Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.39, issue.8, pp.79-84, 2008.
DOI : 10.1016/j.jgyn.2010.10.005

S. Gampenrieder, G. Rinnerthaler, and R. Greil, Neoadjuvant Chemotherapy and Targeted Therapy in Breast Cancer: Past, Present, and Future, Journal of Oncology, vol.21, issue.168, p.732047, 2013.
DOI : 10.1158/0008-5472.SABCS10-S3-3

V. Minckwitz, G. Untch, M. Blohmer, J. Costa, S. Eidtmann et al., Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes, Journal of Clinical Oncology, vol.30, issue.15, pp.1796-1804, 2012.
DOI : 10.1200/JCO.2011.38.8595

D. Sataloff, B. Mason, A. Prestipino, U. Seinige, C. Lieber et al., Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome, J Am Coll Surg. march, vol.180, issue.3, pp.297-306, 1995.

V. Fourchotte and A. Fitoussi, Chirurgie d'ex??r??se totale du sein, 2010.
DOI : 10.1016/B978-2-294-06245-2.50003-6

F. Fitzal and M. Gnant, Breast Conservation: Evolution of Surgical Strategies, The Breast Journal, vol.124, issue.s2, pp.165-173, 2006.
DOI : 10.1016/S0360-3016(03)00589-3

B. Fisher, S. Anderson, J. Bryant, R. Margolese, M. Deutsch et al., Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer, New England Journal of Medicine, vol.347, issue.16, pp.1233-1241, 2002.
DOI : 10.1056/NEJMoa022152

L. Mauriac, G. Macgrogan, A. A. Durand, M. Floquet, A. Debled et al., Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonié Bordeaux Groupe Sein (IBBGS), Annals of Oncology, vol.10, issue.1, pp.47-52, 1999.
DOI : 10.1023/A:1008337009350

N. Wolmark, J. Wang, E. Mamounas, J. Bryant, and B. Fisher, Preoperative Chemotherapy in Patients With Operable Breast Cancer: Nine-Year Results From National Surgical Adjuvant Breast and Bowel Project B-18, JNCI Monographs, vol.2001, issue.30, pp.96-102, 2001.
DOI : 10.1093/oxfordjournals.jncimonographs.a003469

I. Smith and L. Lipton, Preoperative/neoadjuvant medical therapy for early breast cancer, The Lancet Oncology, vol.2, issue.9, pp.561-570, 2001.
DOI : 10.1016/S1470-2045(01)00490-9

A. Fitoussi and . Oncoplastie, Chirurgie du cancer du sein. Traitement conservateur, oncoplastie et reconstruction. Alfred Fitoussi, 2010.

B. Couturaud and F. A. Anatomie, Chirurgie du cancer du sein. Traitement conservateur, oncoplastie et reconstruction, 2010.

M. Morrow, Limiting breast surgery to the proper minimum, The Breast, vol.14, issue.6, pp.523-526, 2005.
DOI : 10.1016/j.breast.2005.08.008

F. Fitzal, O. Riedl, M. Mittlböck, P. Dubsky, R. Bartsch et al., Oncologic safety of breast conserving surgery after tumour downsizing by neoadjuvant therapy: a retrospective single centre cohort study, Breast Cancer Research and Treatment, vol.19, issue.Suppl 5, pp.121-128, 2011.
DOI : 10.1007/s10549-010-1164-9

URL : https://hal.archives-ouvertes.fr/hal-00594469

P. Levine and C. Veneroso, The Epidemiology of Inflammatory Breast Cancer, Seminars in Oncology, vol.35, issue.1, pp.11-16, 2008.
DOI : 10.1053/j.seminoncol.2007.11.018

K. Hance, W. Anderson, S. Devesa, H. Young, and P. Levine, Trends in Inflammatory Breast Carcinoma Incidence and Survival: The Surveillance, Epidemiology, and End Results Program at the National Cancer Institute, JNCI Journal of the National Cancer Institute, vol.97, issue.13, pp.966-975, 2005.
DOI : 10.1093/jnci/dji172

S. Dawood and M. Cristofanilli, What progress have we made in managing inflammatory breast cancer?, Oncol Williston Park N. may, vol.21, issue.6, pp.673-679, 2007.

M. Kell and M. Morrow, Surgical Aspects of Inflammatory Breast Cancer, Breast Disease, vol.22, issue.1, pp.67-73, 2005.
DOI : 10.3233/BD-2006-22108

S. Singletary, Surgical Management of Inflammatory Breast Cancer, Seminars in Oncology, vol.35, issue.1, pp.72-77, 2008.
DOI : 10.1053/j.seminoncol.2007.11.008

M. Lagios, P. Westdahl, and M. Rose, The concept and implications of multicentricity in breast carcinoma, Pathol Annu, vol.16, pp.83-102, 1981.

K. Sikand, A. Lee, S. Pinder, C. Elston, and I. Ellis, Sections of the nipple and quadrants in mastectomy specimens for carcinoma are of limited value, Journal of Clinical Pathology, vol.58, issue.5, pp.543-545, 2005.
DOI : 10.1136/jcp.2004.022665

N. Coombs and J. Boyages, Multifocal and Multicentric Breast Cancer: Does Each Focus Matter?, Journal of Clinical Oncology, vol.23, issue.30, pp.7497-7502, 2005.
DOI : 10.1200/JCO.2005.02.1147

E. Deurloo, K. Zeggelink, W. Teertstra, H. Peterse, J. Rutgers et al., Contrast-enhanced MRI in breast cancer patients eligible for breast-conserving therapy: complementary value for subgroups of patients, European Radiology, vol.275, issue.3, pp.692-701, 2006.
DOI : 10.1007/s00330-005-0043-y

O. Gentilini, E. Botteri, N. Rotmensz, D. Lima, L. Caliskan et al., Conservative surgery in patients with multifocal/multicentric breast cancer, Breast Cancer Research and Treatment, vol.353, issue.3, pp.577-583, 2009.
DOI : 10.1007/s10549-008-9959-7

URL : https://hal.archives-ouvertes.fr/hal-00478324

J. Van-dongen, A. Voogd, I. Fentiman, C. Legrand, R. Sylvester et al., Long-Term Results of a Randomized Trial Comparing Breast-Conserving Therapy With Mastectomy: European Organization for Research and Treatment of Cancer 10801 Trial, Journal of the National Cancer Institute, vol.92, issue.14, pp.1143-1150, 2000.
DOI : 10.1093/jnci/92.14.1143

I. Jaffré, L. Campion, M. Dejode, V. Bordes, C. Sagan et al., Margin Width Should Not Still Enforce a Systematic Surgical Re-excision in the Conservative Treatment of Early Breast Infiltrative Ductal Carcinoma, Annals of Surgical Oncology, vol.9, issue.12, pp.3831-3838, 2013.
DOI : 10.1245/s10434-013-3063-x

S. Molenaar, F. Oort, M. Sprangers, E. Rutgers, E. Luiten et al., Predictors of patients??? choices for breast-conserving therapy or mastectomy: a prospective study, British Journal of Cancer, vol.17, issue.11, pp.2123-2130, 2004.
DOI : 10.1056/NEJMoa020989

R. Nold, R. Beamer, S. Helmer, and M. Mcboyle, Factors influencing a woman???s choice to undergo breast-conserving surgery versus modified radical mastectomy, The American Journal of Surgery, vol.180, issue.6, pp.413-418, 2000.
DOI : 10.1016/S0002-9610(00)00501-8

L. Irwig and A. Bennetts, QUALITY OF LIFE AFTER BREAST CONSERVATION OR MASTECTOMY: A SYSTEMATIC REVIEW, ANZ Journal of Surgery, vol.150, issue.11
DOI : 10.1016/S0140-6736(83)91452-6

S. Al-ghazal, L. Fallowfield, and R. Blamey, Patient evaluation of cosmetic outcome after ! 64

C. Eichler, M. Kolsch, A. Sauerwald, A. Bach, O. Gluz et al., Lumpectomy versus mastopexy--a post-surgery patient survey, Anticancer Res, vol.33, issue.2, pp.731-736, 2013.

S. Al-ghazal, L. Fallowfield, and R. Blamey, Does cosmetic outcome from treatment of primary breast cancer influence psychosocial morbidity?, European Journal of Surgical Oncology (EJSO), vol.25, issue.6, pp.571-573, 1999.
DOI : 10.1053/ejso.1999.0708

F. Fitzal and M. Gnant, Breast Conservation: Evolution of Surgical Strategies, The Breast Journal, vol.124, issue.s2, pp.165-173, 2006.
DOI : 10.1016/S0360-3016(03)00589-3

C. Fisher, T. Martin-dunlap, M. Ruppel, F. Gao, J. Atkins et al., Fear of Recurrence and Perceived Survival Benefit are Primary Motivators for Choosing Mastectomy over Breast-Conservation Therapy Regardless of Age, Annals of Surgical Oncology, vol.29, issue.16, pp.3246-3250, 2012.
DOI : 10.1245/s10434-012-2525-x

L. Mauriac, M. Durand, A. Avril, and J. Dilhuydy, Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre, Ann Oncol Off J Eur Soc Med Oncol ESMO. mai, vol.2, issue.5, pp.347-354, 1991.

A. Chen, F. Meric-bernstam, K. Hunt, H. Thames, E. Outlaw et al., Breast conservation after neoadjuvant chemotherapy. Cancer, pp.689-695, 2005.

S. Abrous-anane, A. Savignoni, C. Daveau, J. Pierga, C. Gautier et al., Traitement locor??gional du cancer du sein inflammatoire apr??s chimioth??rapie n??oadjuvante, Cancer/Radioth??rapie, vol.15, issue.8, pp.654-662, 2011.
DOI : 10.1016/j.canrad.2011.01.009

P. Therasse, S. Arbuck, E. Eisenhauer, J. Wanders, R. Kaplan et al., New Guidelines to Evaluate the Response to Treatment in Solid Tumors, JNCI: Journal of the National Cancer Institute, vol.92, issue.3, pp.205-216, 2000.
DOI : 10.1093/jnci/92.3.205

E. Eisenhauer, P. Therasse, J. Bogaerts, L. Schwartz, D. Sargent et al., New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1), European Journal of Cancer, vol.45, issue.2, pp.228-247, 1990.
DOI : 10.1016/j.ejca.2008.10.026

D. Fumagalli, P. Bedard, Z. Nahleh, S. Michiels, C. Sotiriou et al., A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints, The Lancet Oncology, vol.13, issue.6, pp.240-248, 2012.
DOI : 10.1016/S1470-2045(11)70378-3

C. Perou, T. Sørlie, M. Eisen, M. Van-de-rijn, S. Jeffrey et al., Molecular portraits of human breast tumours, Nature, vol.406, issue.6797, pp.747-752, 2000.
DOI : 10.1038/35021093

T. Sørlie, C. Perou, R. Tibshirani, T. Aas, S. Geisler et al., Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proceedings of the National Academy of Sciences, vol.98, issue.19, pp.10869-10874, 2001.
DOI : 10.1073/pnas.191367098

D. Mauri, N. Pavlidis, and J. Ioannidis, Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-Analysis, JNCI Journal of the National Cancer Institute, vol.97, issue.3, pp.188-194, 2005.
DOI : 10.1093/jnci/dji021

C. Early-breast, . Trialists-'collaborative, . Group, . Ebctcg-), S. Darby et al., Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials, Lancet. 12 nov, vol.378, issue.9804, pp.1707-1716, 2011.

S. Litière, G. Werutsky, I. Fentiman, E. Rutgers, M. Christiaens et al., Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow, p.65

J. Van-der-hage, C. Van-de-velde, J. Julien, M. Tubiana-hulin, C. Vandervelden et al., Preoperative Chemotherapy in Primary Operable Breast Cancer: Results From the European Organization for Research and Treatment of Cancer Trial 10902, Journal of Clinical Oncology, vol.19, issue.22, pp.4224-4237, 2001.
DOI : 10.1200/JCO.2001.19.22.4224

J. Mieog, J. Van-der-hage, and C. Van-de-velde, Neoadjuvant chemotherapy for operable breast cancer, British Journal of Surgery, vol.23, issue.10, pp.1189-1200, 2007.
DOI : 10.1002/bjs.5894

L. Degner, L. Kristjanson, D. Bowman, J. Sloan, K. Carriere et al., Information Needs and Decisional Preferences in Women With Breast Cancer, JAMA: The Journal of the American Medical Association, vol.277, issue.18, pp.1485-1492, 1997.
DOI : 10.1001/jama.1997.03540420081039

R. Rouzier, M. Mathieu, L. Sideris, E. Youmsi, R. Rajan et al., Breast-conserving surgery after neoadjuvant anthracycline-based chemotherapy for large breast tumors, Cancer, vol.101, issue.5, pp.918-925, 2004.
DOI : 10.1002/cncr.20491

C. Mueller and M. Lesperance, NSABP Trials of Adjuvant Chemotherapy for Breast Cancer, Annals of Surgery, vol.214, issue.3, pp.206-212, 1991.
DOI : 10.1097/00000658-199109000-00003

R. Smith, S. Anderson, A. Brown, A. Scholnik, A. Desai et al., Phase II Trial of Doxorubicin/Docetaxel/Cyclophosphamide for Locally Advanced and Metastatic Breast Cancer: Results from NSABP Trial BP-58, Clinical Breast Cancer, vol.3, issue.5, pp.333-340, 2002.
DOI : 10.3816/CBC.2002.n.036

R. Rouzier, L. Pusztai, J. Garbay, S. Delaloge, K. Hunt et al., Development and validation of nomograms for predicting residual tumor size and the probability of successful conservative surgery with neoadjuvant chemotherapy for breast cancer, Cancer, vol.23, issue.7, pp.1459-1466, 2006.
DOI : 10.1002/cncr.22177

H. Shin, W. Han, H. Moon, S. Im, W. Moon et al., Breast-Conserving Surgery After Tumor Downstaging by Neoadjuvant Chemotherapy is Oncologically Safe for Stage III Breast Cancer Patients, Annals of Surgical Oncology, vol.127, issue.2, pp.2582-2589, 2013.
DOI : 10.1245/s10434-013-2909-6

F. Fitzal, O. Riedl, L. Wutzl, W. Draxler, M. Rudas et al., Breast-conserving surgery for T3/T4 breast cancer: an analysis of 196 patients, Breast Cancer Research and Treatment, vol.58, issue.2, pp.45-52, 2007.
DOI : 10.1007/s10549-006-9325-6

E. Romond, J. Jeong, P. Rastogi, S. Swain, C. Geyer et al., Seven-Year Follow-Up Assessment of Cardiac Function in NSABP B-31, a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel (ACP) With ACP Plus Trastuzumab As Adjuvant Therapy for Patients With Node-Positive, Human Epidermal Growth Factor Receptor 2???Positive Breast Cancer, Journal of Clinical Oncology, vol.30, issue.31, pp.3792-3799, 2012.
DOI : 10.1200/JCO.2011.40.0010

E. Perez, V. Suman, N. Davidson, S. Martino, P. Kaufman et al., Testing by Local, Central, and Reference Laboratories in Specimens From the North Central Cancer Treatment Group N9831 Intergroup Adjuvant Trial, Journal of Clinical Oncology, vol.24, issue.19, pp.3032-3038, 2006.
DOI : 10.1200/JCO.2005.03.4744

J. Nabholtz, D. Reese, M. Lindsay, and A. Riva, HER2-Positive Breast Cancer: Update on Breast Cancer International Research Group Trials, Clinical Breast Cancer, vol.3, issue.2, pp.75-79, 2002.
DOI : 10.3816/CBC.2002.s.016

P. Spanheimer, J. Carr, A. Thomas, S. Sugg, C. Scott-conner et al., The response to neoadjuvant chemotherapy predicts clinical outcome and increases breast conservation in advanced breast cancer, The American Journal of Surgery, vol.206, issue.1, pp.2-7, 2013.
DOI : 10.1016/j.amjsurg.2012.10.025

R. Rouzier, C. Perou, W. Symmans, N. Ibrahim, M. Cristofanilli et al., Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy, Clinical Cancer Research, vol.11, issue.16, p.66
DOI : 10.1158/1078-0432.CCR-04-2421

C. Criscitiello, H. Azim, . Jr, D. Agbor-tarh, E. De-azambuja et al., Factors associated with surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial, Annals of Oncology, vol.24, issue.8, pp.1980-1985, 2013.
DOI : 10.1093/annonc/mdt129

M. Debled, G. Macgrogan, C. Breton-callu, S. Ferron, G. Hurtevent et al., Surgery following neoadjuvant chemotherapy for Her-2 positive locally advanced breast cancer. Time to reconsider the standard attitude, 2014.

M. Panades, I. Olivotto, C. Speers, T. Shenkier, T. Olivotto et al., Evolving Treatment Strategies for Inflammatory Breast Cancer: A Population-Based Survival Analysis, Journal of Clinical Oncology, vol.23, issue.9, pp.1941-1950, 2005.
DOI : 10.1200/JCO.2005.06.233

R. Fleming, L. Asmar, A. Buzdar, M. Mcneese, F. Ames et al., Effectiveness of mastectomy by response to induction chemotherapy for control in inflammatory breast carcinoma, Annals of Surgical Oncology, vol.83, issue.6, pp.452-461, 1997.
DOI : 10.1007/BF02303668

D. Boer, R. Allum, W. Ebbs, S. Gui, G. Johnston et al., Multimodality therapy in inflammatory breast cancer: is there a place for surgery?, Annals of Oncology, vol.11, issue.9, pp.1147-1153, 2000.
DOI : 10.1023/A:1008374931854

E. Touboul, J. Lefranc, J. Blondon, L. Buffat, E. Deniaud et al., Primary chemotherapy and preoperative irradiation for patients with stage II larger than 3 cm or locally advanced non-inflammatory breast cancer, Radiotherapy and Oncology, vol.42, issue.3, pp.219-229, 1997.
DOI : 10.1016/S0167-8140(97)01923-3

N. Ditsch, A. Vodermaier, A. Hinke, S. Burghardt, M. Lenhard et al., Dose-dense intensified sequential versus conventionally-dosed anthracycline and taxane-containing neoadjuvant therapy in patients with inflammatory breast cancer, Anticancer Res. aug, vol.32, issue.8, pp.3539-3545, 2012.

S. Ohsumi, K. Shimozuma, K. Shimozumai, K. Kuroi, M. Ono et al., Quality of life of breast cancer patients and types of surgery for breast cancer ??? Current status and unresolved issues ???, Breast Cancer, vol.89, issue.1, pp.66-73, 2007.
DOI : 10.2325/jbcs.14.66

N. Janz, C. Friese, Y. Li, J. Graff, A. Hamilton et al., Emotional well-being years posttreatment for breast cancer: prospective, multi-ethnic, and population-based analysis, J Cancer Surviv Res Pract. 13 nov, 2013.

P. Parker, A. Youssef, S. Walker, K. Basen-engquist, L. Cohen et al., Short-Term and Long-Term Psychosocial Adjustment and Quality of Life in Women Undergoing Different Surgical Procedures for Breast Cancer, Annals of Surgical Oncology, vol.74, issue.11, pp.3078-3089, 2007.
DOI : 10.1245/s10434-007-9413-9

T. Takahashi, M. Hondo, K. Nishimura, A. Kitani, T. Yamano et al., Evaluation of quality of life and psychological response in cancer patients treated with radiotherapy, Radiation Medicine, vol.354, issue.1, pp.396-401, 2008.
DOI : 10.1007/s11604-008-0248-5

P. Kenny, M. King, A. Shiell, J. Seymour, J. Hall et al., Early stage breast cancer: costs and quality of life one year after treatment by mastectomy or conservative surgery and radiation therapy, The Breast, vol.9, issue.1, pp.37-44, 2000.
DOI : 10.1054/brst.1999.0111

M. Pandey, B. Thomas, K. Ramdas, and K. Ratheesan, Early Effect of Surgery on Quality of Life in Women with Operable Breast Cancer, Japanese Journal of Clinical Oncology, vol.36, issue.7, pp.468-472, 2006.
DOI : 10.1093/jjco/hyl065

A. Munshi, D. Dutta, S. Kakkar, A. Budrukkar, R. Jalali et al., Comparison of early quality of life in patients treated with radiotherapy following mastectomy or breast conservation therapy: A prospective study, Radiotherapy and Oncology, vol.97, issue.2, pp.288-293, 2010.
DOI : 10.1016/j.radonc.2010.04.008

J. Engel, J. Kerr, A. Schlesinger-raab, H. Sauer, and D. Hölzel, Quality of Life Following Breast-Conserving Therapy or Mastectomy: Results of a 5-Year Prospective Study, The Breast Journal, vol.65, issue.3, pp.223-231, 2004.
DOI : 10.1023/A:1008936830764

J. Oh, M. Dryden, W. Woodward, T. Yu, W. Tereffe et al., Locoregional Control of Clinically Diagnosed Multifocal or Multicentric Breast Cancer After Neoadjuvant Chemotherapy and Locoregional Therapy, Journal of Clinical Oncology, vol.24, issue.31, pp.4971-4975, 2006.
DOI : 10.1200/JCO.2006.07.6067

E. Rakovitch, J. Pignol, C. Chartier, W. Hanna, H. Kahn et al., The management of ductal carcinoma in situ of the breast: a screened population-based analysis, Breast Cancer Research and Treatment, vol.23, issue.24, pp.335-347, 2007.
DOI : 10.1007/s10549-006-9302-0

G. Viani, E. Stefano, S. Afonso, D. Fendi, L. Soares et al., Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials, Radiation Oncology, vol.2, issue.1, p.28, 2007.
DOI : 10.1186/1748-717X-2-28

E. Mamounas, S. Anderson, J. Dignam, H. Bear, T. Julian et al., Predictors of Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From Combined Analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27, Journal of Clinical Oncology, vol.30, issue.32, pp.3960-3966, 2012.
DOI : 10.1200/JCO.2011.40.8369

E. Breast-cancer-cooperative, . Group, . Eortc-radiotherapy-group, N. Bijker, P. Meijnen et al., Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group, J Clin Oncol Off J Am Soc Clin Oncol. 20 jul, vol.24, issue.21, pp.3381-3387, 2006.

J. Houghton, Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomized controlled trial, The Lancet, vol.362, issue.9378, pp.95-102, 2003.
DOI : 10.1016/S0140-6736(03)13859-7

S. Emdin, B. Granstrand, A. Ringberg, K. Sandelin, L. Arnesson et al., SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening, Acta Oncologica, vol.16, issue.5, pp.536-543, 2006.
DOI : 10.1016/0277-5379(90)90114-9

P. Neira, B. Aguirre, T. Taub, L. Gutiérrez, C. Sáez et al., Carcinoma ductal in situ: correlaci??n entre la histolog??a y la resonancia magn??tica de mama, Radiolog??a, vol.51, issue.4, pp.396-402, 2009.
DOI : 10.1016/j.rx.2009.01.006

C. Kuhl, S. Schrading, H. Bieling, E. Wardelmann, C. Leutner et al., MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study, The Lancet, vol.370, issue.9586, pp.485-492, 2007.
DOI : 10.1016/S0140-6736(07)61232-X

L. Mauriac, G. Macgrogan, A. A. Durand, M. Floquet, A. Debled et al., Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonié Bordeaux Groupe Sein (IBBGS), Annals of Oncology, vol.10, issue.1, pp.47-52, 1999.
DOI : 10.1023/A:1008337009350

M. El-didi, M. Moneer, H. Khaled, and S. Makarem, Pathological Assessment of the Response of Locally Advanced Breast Cancer to Neoadjuvant Chemotherapy and Its Implications for Surgical Management, Surgery Today, vol.181, issue.3, pp.249-254, 2000.
DOI : 10.1007/s005950050054

S. Coopey, B. Smith, S. Hanson, J. Buckley, K. Hughes et al., The Safety of Multiple Re-excisions after Lumpectomy for Breast Cancer, Annals of Surgical Oncology, vol.14, issue.13, pp.3797-3801, 2011.
DOI : 10.1245/s10434-011-1802-4

T. Fukutomi, Clinical practice and outcome of breast-conserving treatment: The effectiveness of preoperative systemic chemotherapy, Breast Cancer, vol.9, issue.2, pp.147-151, 2006.
DOI : 10.2325/jbcs.13.147

R. Rouzier, J. Extra, M. Carton, M. Falcou, A. Vincent-salomon et al., Primary Chemotherapy for Operable Breast Cancer: Incidence and Prognostic Significance of Ipsilateral Breast Tumor Recurrence After Breast-Conserving Surgery, Journal of Clinical Oncology, vol.19, issue.18, pp.3828-3835, 2001.
DOI : 10.1200/JCO.2001.19.18.3828

B. Fisher, J. Dignam, N. Wolmark, E. Mamounas, J. Costantino et al., Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17., Journal of Clinical Oncology, vol.16, issue.2, pp.441-452, 1998.
DOI : 10.1200/JCO.1998.16.2.441

H. Kuerer, S. Singletary, A. Buzdar, F. Ames, V. Valero et al., Surgical conservation planning after neoadjuvant chemotherapy for stage II and operable stage III breast carcinoma, The American Journal of Surgery, vol.182, issue.6, pp.601-608, 2001.
DOI : 10.1016/S0002-9610(01)00793-0

M. Khanna, R. Mark, M. Silverstein, G. Juillard, B. Lewinsky et al., Breast Conservation Management of Breast Tumors 4 cm or Larger, Archives of Surgery, vol.127, issue.9, pp.1038-1041, 1960.
DOI : 10.1001/archsurg.1992.01420090042007